Amneal Pharmaceuticals, Inc. (AMRX)
20.38
-0.10
(-0.49%)
USD |
NASDAQ |
Oct 23, 16:00
20.37
-0.01
(-0.05%)
After-Hours: 20:00
Amneal Pharmaceuticals Market Cap : 6.508B for Oct. 23, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 23, 2026 | 6.508B |
| October 22, 2026 | 6.540B |
| October 21, 2026 | 6.450B |
| October 20, 2026 | 6.336B |
| October 19, 2026 | 6.182B |
| October 16, 2026 | 6.125B |
| October 15, 2026 | 6.147B |
| October 14, 2026 | 6.035B |
| October 13, 2026 | 6.249B |
| October 12, 2026 | 6.396B |
| October 09, 2026 | 6.358B |
| October 08, 2026 | 6.275B |
| October 07, 2026 | 6.275B |
| October 06, 2026 | 6.481B |
| October 05, 2026 | 6.498B |
| October 02, 2026 | 6.482B |
| October 01, 2026 | 6.409B |
| September 30, 2026 | 6.431B |
| September 29, 2026 | 6.450B |
| September 28, 2026 | 6.546B |
| September 25, 2026 | 6.313B |
| September 24, 2026 | 6.324B |
| September 23, 2026 | 6.173B |
| September 22, 2026 | 6.227B |
| September 21, 2026 | 6.438B |
| Date | Value |
|---|---|
| September 18, 2026 | 5.975B |
| September 17, 2026 | 5.837B |
| September 16, 2026 | 5.773B |
| September 15, 2026 | 5.317B |
| September 14, 2026 | 5.499B |
| September 11, 2026 | 5.432B |
| September 10, 2026 | 5.387B |
| September 09, 2026 | 5.508B |
| September 08, 2026 | 5.445B |
| September 04, 2026 | 5.569B |
| September 03, 2026 | 5.706B |
| September 02, 2026 | 5.767B |
| September 01, 2026 | 5.646B |
| August 31, 2026 | 5.579B |
| August 28, 2026 | 5.601B |
| August 27, 2026 | 5.751B |
| August 26, 2026 | 5.745B |
| August 25, 2026 | 5.722B |
| August 24, 2026 | 5.678B |
| August 21, 2026 | 5.719B |
| August 20, 2026 | 5.716B |
| August 19, 2026 | 5.783B |
| August 18, 2026 | 5.809B |
| August 17, 2026 | 5.882B |
| August 14, 2026 | 5.796B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Liquidia Corp. | 3.800B |
| Eli Lilly & Co. | 1.199T |
| Johnson & Johnson | 635.02B |
| Merck & Co., Inc. | 358.62B |
| Viatris, Inc. | 20.79B |
Market Cap Related Metrics
| PE Ratio | 42.53 |
| PS Ratio | 2.141 |
| PEG Ratio | 0.0057 |
| Price to Book Value | 197.06 |
| Price | 20.38 |
| Earnings Yield | 2.35% |
| PEGY Ratio | 0.0057 |
| Operating PE Ratio | 13.99 |
| Normalized PE Ratio | 32.80 |